Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
VasoView HemoPro 2 Device for Coronary Bypass Surgeries Recalled After Injury Reports: FDA Manufacturer is warning healthcare providers to carefully inspect devices following at least seven reported injuries. January 16, 2025 Darian Hauf Add Your Comments An urgent medical device notification has been issued to physicians over problems with Getinge and Maquet Cardiovascular VasoView HemoPro 2 Endoscopic Vessel Harvesting (EVH) systems, which may have faulty heater wires and silicone attachments. VasoView HemoPro 2 EVH systems are used during minimally invasive surgeries, such as coronary bypass graft surgery, to obtain blood vessels from within the patient’s body, which can then be used to create new bypasses and restore blood flow to the heart. The device consists of a set of tools, including an endoscope, specialized instruments for vessel dissection and retrieval, and a heater wire designed to regulate temperature during the procedure. The U.S. Food and Drug Administration (FDA) announced the Getinge and Maquet VasoView HemoPro 2 recall on January 15, warning healthcare professionals to review safety guidelines, as defects in the devices could result in serious health risks, including bleeding, burns, injuries, blood vessel blockages, infections and even death. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Getinge and Maquet first issued an Urgent Medical Device Correction letter for the VasoView HemoPro 2 EVH system on December 9, 2024, due to the potential risk of the heater wire bending or becoming detached, or the silicone peeling and detaching from the jaws of the harvesting tool during use. The manufacturer has become aware of at least four injuries related to the heater wire, and three more linked to the silicone peeling or detaching. As a result, the FDA has classified this action as a Class I recall, the most serious type, indicating that continued use of the product could result in serious injury or death. The recall involves Getinge and Maquet Cardiovascular VasoView HemoPro 2 Endoscopic Vessel Harvesting Systems, both with a Vasoshield (VH-4001) and without (VH-4000). Affected Unique Device Identifiers (UDI) and models include: 00607567700406/VH-4000 and 00607567700451/VH-4001. Healthcare providers were previously alerted to an older VasoView HemoPro EVH system recall through an Urgent Medical Device Field Correction letter on November 15, following 17 reports of serious injuries caused by faulty heater wires and silicone on the VasoView HemoPro 1 and 1.5 EVH systems. These are the same issues that are now affecting the VasoView HemoPro 2 EVH system. The FDA’s original letter to health care providers recommends the following actions: Review the Instructions for Use and the FDA’s letter before using the affected device. Pay special attention to warnings about minimizing the amount of energy used. Inspect the device prior, during and after use for any signs of damage, including silicone detaching from the jaws, rough outer surfaces, sharp edges or unusual protrusions that may pose a hazard. Stop using the device if there are missing or damaged parts or any silicone peeling. Monitor patients for complications if it is suspected that fragments of the device may have been left inside of them, then locate and remove any components which may have fragmented inside the patient. The manufacturer requests that customers complete and sign the Medical Device Removal Response Form attached to the letter and return it to Maquet Cardiovascular/Getinge by email at Hemopro-peeling-detachedsilicone2024.act@getinge.com or fax to 1-866-594-8101. For more information, customers can contact Maquet Cardiovascular/Getinge customer support at 1-888-880-2874 or the FDA’s Division of Industry and Consumer Education. Tags: Coronary Bypass Surgery, Endoscopic Vessel Harvesting, EVH System, Getinge and Maquet, VasoView HemoPro 2 Image Credit: FDA More Lawsuit Stories Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 March 14, 2025 At Least 8 Lawsuits Over Oxbryta Filed Against Pfizer, Global Blood Therapeutics March 14, 2025 Judge Calls for Change Healthcare Data Breach Lawsuits in State and Federal Courts To Be Coordinated March 14, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (Posted: yesterday) Parties involved in Covidien hernia mesh lawsuits indicate they are ready to meet with a mediator in a couple weeks to begin potential settlement negotiations. MORE ABOUT: HERNIA MESH LAWSUITCovidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)Discovery Deadlines in Covidien Hernia Mesh Lawsuits Extended by MDL Judge (12/12/2024)Court Appoints Bard Hernia Mesh Settlement Special Masters To Implement “Intensive” Process To Resolve Claims (11/22/2024) Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (Posted: 2 days ago) A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025) Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: 3 days ago) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)
Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 March 14, 2025
Judge Calls for Change Healthcare Data Breach Lawsuits in State and Federal Courts To Be Coordinated March 14, 2025
Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (Posted: yesterday) Parties involved in Covidien hernia mesh lawsuits indicate they are ready to meet with a mediator in a couple weeks to begin potential settlement negotiations. MORE ABOUT: HERNIA MESH LAWSUITCovidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)Discovery Deadlines in Covidien Hernia Mesh Lawsuits Extended by MDL Judge (12/12/2024)Court Appoints Bard Hernia Mesh Settlement Special Masters To Implement “Intensive” Process To Resolve Claims (11/22/2024)
Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (Posted: 2 days ago) A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025)
Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: 3 days ago) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)